Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
- PMID: 40323371
- PMCID: PMC12084428
- DOI: 10.1007/s40744-025-00761-x
Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Erratum for
-
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies.Rheumatol Ther. 2024 Oct;11(5):1363-1382. doi: 10.1007/s40744-024-00708-8. Epub 2024 Aug 31. Rheumatol Ther. 2024. PMID: 39215949 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources